Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
Diabetes Care · 01.06.2023 · 46 (6) · 1191-1195
DOI: 10.2337/dc22-2348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 12.04.2023. Verfasst von Jack K C Ng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Peritoneal Dialysis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Health and Medical Research Fund Commisionned Program for Phase 1 Clinical Trial Centre, Medtronic External Research Program.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE To evaluate the performance of a real-time continuous glucose monitor (CGM) in individuals with diabetes on peritoneal dialysis (PD). RESEARCH DESIGN AND METHODS Thirty participants with type 2 diabetes on continuous ambulatory PD wore a Guardian Sensor 3 on the upper arm paired with Guardian Connect for 14 days. We compared CGM readings against Yellow Springs Instrument (YSI) venous glucose during an 8-h in-clinic session with glucose challenge. RESULTS The mean absolute relative difference (MARD) was 10.4% (95% CI 9.6, 11.7) from 941 CGM-YSI matched pairs; 81.3% of readings were within %15/15 of YSI values in the full glycemic range. Consensus error grid analysis showed 99.9% of sensor values in zones A and B. There were no correlations between pH, uremia, hydration status, and MARD. CONCLUSIONS We showed satisfactory performance of a real-time CGM sensor in PD patients with diabetes, supporting future use to facilitate treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR.
- Phase 1 Clinical Trial Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR.
- Hong Kong Institute of Diabetes and Obesity,Hong Kong SAR.
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR.
ORCID-Profile: Elaine Chow
Förderung
- Health and Medical Research Fund Commisionned Program for Phase 1 Clinical Trial Centre
- Medtronic External Research Program
Zitieren
APA
Ng, J. K. C., Ling, J., Luk, A. O. Y., Lau, E. S. H., Ma, R. C. W., Li, P. K. T., Szeto, C. C., Chan, J. C. N., & Chow, E. (2023). Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis. Diabetes Care, 46(6), 1191-1195. https://doi.org/10.2337/dc22-2348
Vancouver
Ng JKC, Ling J, Luk AOY, Lau ESH, Ma RCW, Li PKT, et al. Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis. Diabetes Care. 2023;46(6):1191-1195. doi:10.2337/dc22-2348
BibTeX
@article{Ng2023,
author = {Ng, Jack K C and Ling, James and Luk, Andrea O Y and Lau, Eric S H and Ma, Ronald C W and Li, Philip K T and Szeto, Cheuk Chun and Chan, Juliana C N and Chow, Elaine},
title = {Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis},
journal = {Diabetes Care},
year = {2023},
volume = {46},
number = {6},
pages = {1191--1195},
doi = {10.2337/dc22-2348}
}
EUVIMED